摘要
当癌症处于中晚期后再采取治疗措施,所需治疗费用非常昂贵,且很难根治,而采用液体芯片——飞行时间质谱技术检测,只需要不到1000元。
出处
《中国医院院长》
2006年第14期70-71,共2页
China Hospital CEO
同被引文献21
-
1Leung SM,Mok SC. A new approach to profile ovarian cancer serum using functionalized magnetic beads, AnchorChipTM technology. MALDI TOF MS, MALDI-TOF/TOF MS and bioinformatics. Mol Cell Proteomics, 2003,2 : 31.
-
2Leung SM, Mok SC. Quality management of ovarian cancer profiles using functionalizied magnetic beads, AnchorChip ( TM ) technology, MALDI-TOF MS and, MALDI-TOF/TOF MS. Proceedings of the American Association for Cancer Research Annual Meeting, 2004,45: 1205.
-
3Villanueva J, Philip J, Entenberg D, et al. Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALD1 TOF mass spectrometry. Anal Chem, 2004,76:1560-1570.
-
4Cazares I.H, Mitchell Green Shamina, Leung SM, et al. Serum protein expression patterns in head and neck cancer for biomarker discovery and identification using MALDI-TOF/ TOF MS. Proceedings of the American Association for Cancer Research Annual Meeting, 2005,46 : 1132.
-
5Freed GL. Cazares LH, Fichandler CE, et al. Differential capture of serum proteins for expression profiling and biomarker discovery in pre-and posttreatment head and neck cancer samples. Laryngoscope, 2008,118:61-68.
-
6Leung SM,Sheldon M,Lau CC. A novel and rapid approaich to protein expression profiling of cerebrospinal fluid (CSF) from medulloblastoma patients using functionalizied magnetic beads, AnchorChip(TM) technology, MALDI-TOF and MALDI-TOF/TOF mass spectrometry. Neuro-Oneology, 2004,6:410.
-
7Chang JT, Chen LC, Wei SY, et al. Increase diagnostic efficacy by combined use of fingerprint markers in mass spectrometryplasma peptidomes frora nasopharyngeal cancer patients for example. Clin Biochem, 2006,39 : 1144-1151.
-
8Cheng AJ, Chen LC, Chien KY, et al. Oral cancer plasma tumor marker identified with bead-based affinity-fractionated proteomic technology. Clin Chem, 2005,51 : 2236-2244.
-
9Villanueva J, Nazarian A,Lawlor K,et al. A sequence-specific exopeptidase activity test ( SSEAT ) for " functional " biomarker discovery. Mol Cell Proteomics, 2008,7 : 509-518.
-
10Villanueva J, Shaffer DR, Philip J, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest, 2006,116 : 271-284.
二级引证文献1
-
1BU Li-na,YANG Shuan-ying,LI Feng-tao,SHANG Wen-li,ZHANG Wei,HUO Shu-fen,NAN Yan-dong,TIAN Ying-xuan,DU Jie,LIN Xiu-li,LIU Yan-feng,LIN Yu-rong,RONG Biao-xue.Study of differential proteins in lung adenocarcinoma using laser capture microdissection combined with liquid chip-mass spectrometry technology[J].Chinese Medical Journal,2010(22):3309-3313.
-
1王琴,石远凯.免疫检查点抑制剂在肿瘤治疗中的重大突破[J].中华医学杂志,2016,96(28):2281-2284. 被引量：6
-
2张健,陶朝晖,景莉,韩丽英.表面增强激光解吸/电离-飞行时间质谱技术检测不同来源淋巴瘤细胞株及健康人外周淋巴细胞的差异蛋白质[J].白血病．淋巴瘤,2010,19(8):486-488. 被引量：1
-
3赖晓龙,陆才德.肝内胆管细胞癌发生的分子机制研究进展[J].浙江医学,2017,39(2):139-141. 被引量：5
-
4宋国英,高春芳,赵光,叶成果.利用SELDI-TOF-MS技术从结直肠癌患者血清中筛选特异的生物标记物[J].河南科技大学学报（医学版）,2006,24(3):177-179.
-
5朱江,邓智平,宋张骏,张锋,韩丕华,王治伦.小细胞肺癌患者血清差异表达蛋白分析[J].现代肿瘤医学,2013,21(3):530-533.
-
6闫庆国,王哲,师建国.分子靶向治疗引领的肺癌病理诊断与分型进展[J].现代肿瘤医学,2015,23(16):2396-2398. 被引量：3
-
7杨娟,杨栓盈,倪磊,宋土生,于林,黄辰.慢性阻塞性肺疾病患者的血清差异表达蛋白分析[J].西安交通大学学报（医学版）,2012,33(1):61-64. 被引量：1
-
8刘霆.费城染色体阳性急性淋巴细胞性白血病,引领治疗模式的转变[J].临床血液学杂志,2016,29(2):181-185. 被引量：2
-
9韦叶生,蓝艳,黄瑞雅,蒙兰青,徐群清,解海源.用SELDI蛋白芯片技术筛选缺血性脑卒中患者血清蛋白标志物的研究[J].分子诊断与治疗杂志,2010,2(2):77-80. 被引量：5
-
10何英,唐利立.蛋白组学与乳腺癌[J].中国普通外科杂志,2004,13(11):849-851.
